Creative Medical Technology Holdings (CELZ) Return on Capital Employed (2016 - 2025)

Creative Medical Technology Holdings (CELZ) has disclosed Return on Capital Employed for 15 consecutive years, with 0.94% as the latest value for Q4 2025.

  • Quarterly Return on Capital Employed fell 5.0% to 0.94% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.94% through Dec 2025, down 5.0% year-over-year, with the annual reading at 0.88% for FY2025, 20.0% down from the prior year.
  • Return on Capital Employed for Q4 2025 was 0.94% at Creative Medical Technology Holdings, up from 0.98% in the prior quarter.
  • The five-year high for Return on Capital Employed was 2.15% in Q2 2021, with the low at 0.98% in Q3 2025.
  • Average Return on Capital Employed over 5 years is 0.37%, with a median of 0.6% recorded in 2023.
  • The sharpest move saw Return on Capital Employed surged 187bps in 2021, then plummeted -247bps in 2022.
  • Over 5 years, Return on Capital Employed stood at 0.51% in 2021, then fell by -15bps to 0.59% in 2022, then grew by 15bps to 0.5% in 2023, then tumbled by -78bps to 0.89% in 2024, then decreased by -5bps to 0.94% in 2025.
  • According to Business Quant data, Return on Capital Employed over the past three periods came in at 0.94%, 0.98%, and 0.79% for Q4 2025, Q3 2025, and Q2 2025 respectively.